Bone Biologics Corp — Director's Dealing 2019

May 24, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Bone Biologics Corp (BBLG)
CIK: 0001419554
Period of Report: 2019-05-07

Reporting Person: Hankey Bret (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-05-07	Common Stock	P	1063830	—	Acquired	26127733	Indirect

Footnotes

F1: Consists of shares held by Hankey Capital LLC ("Hankey Capital") as collateral for the repayment of convertible notes (the "Notes") issued to Hankey Capital (the "Collateral Shares"). Hankey Capital may not transfer, sell or otherwise dispose of any of the Collateral Shares, except during the existence of Event of Default under the Notes in connection with the exercise of its rights and remedies as a secured lender.

F2: Hankey Capital is owned by Hankey Investment Company LP ("HIC") of which the Bret Hankey Trust (the "Bret Trust") owns a 5.83% interest, the Rufus and Bret Hankey Trust (the "RB Trust") owns a 0.94% interest and the Hankey Children's Trust (the "Children's Trust") owns a 0.99% interest. Mr. Hankey is the settlor and trustee of the Bret Trust and Mr. Hankey's immediate family are beneficiaries of the Bret Trust; Mr. Hankey is one of the settlors of the RB Trust, of which, the Bret Trust is one of the beneficiaries and Mr. Hankey is a successor trustee of the Children's Trust. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his or his immediate family's pecuniary interest.

F3: Consists of shares held by Hankey Capital. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his or his immediate family's pecuniary interest.